Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Vaxart Inc VXRT

Healthcare Biotechnology

Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its... see more

Add To Watchlist

Recent & Breaking News (NDAQ:VXRT)

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors of Securities Fraud Class Action and Encourages Investors with Significant Losses to Contact the Firm, Application Deadline Approaching

GlobeNewswire September 14, 2020

Vaxart Investors With Significant Losses Encouraged To Contact Kehoe Law Firm, P.C.

GlobeNewswire September 14, 2020

VXRT, BLNK, PLAN Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Plaintiff Deadlines

ACCESSWIRE IA September 14, 2020

Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program

GlobeNewswire September 14, 2020

FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA September 12, 2020

Portnoy Law: Lawsuit Filed On Behalf of OneSpan Inc., Vaxart Inc., Anaplan, Inc., & Blink Charging Company Investors

GlobeNewswire September 11, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Vaxart (VXRT) Investors with Significant Losses to Contact the Firm, Securities Fraud Class Action Filed and Application Deadline Approaching

Newsfile September 11, 2020

VXRT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 23, 2020 in the Class Action Filed on Behalf of Vaxart, Inc. Limited Shareholders

Newsfile September 11, 2020

DEADLINE ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA September 11, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Vaxart, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2020 - VXRT

Newsfile September 11, 2020

DEADLINE ALERT for OSPN, VXRT, PLAN, and BLNK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire September 11, 2020

SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA September 10, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Vaxart (VXRT) Investors with Significant Losses to Contact the Firm Now, Securities Fraud Class Action Filed and Application Deadline Approaching

Newsfile September 10, 2020

VAXART, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Lawsuit Has Been Filed on Behalf of Shareholders of Vaxart, Inc. in the United States District Court for the Northern District of California

GlobeNewswire September 10, 2020

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Vaxart, Inc. (VXRT)

GlobeNewswire September 10, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qutoutiao, Vaxart, Anaplan, and Blink Charging and Encourages Investors to Contact the Firm

GlobeNewswire September 9, 2020

Investor Alert: Kaplan Fox Investigates Vaxart For Potential Securities Fraud

PR Newswire September 9, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Vaxart (VXRT) Investors with Significant Losses to Contact the Firm Now, Securities Fraud Class Action Filed and Important Deadline is Approaching

Newsfile September 9, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Vaxart, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2020 - VXRT

Newsfile September 8, 2020

ROSEN, A TOP RANKED LAW FIRM, Reminds Vaxart, Inc. Investors of Important Deadline in Securities Class Action - VXRT

GlobeNewswire September 8, 2020